Cellmover
Preclinical nanobody therapeutics for cancer immunotherapy and autoimmune diseases
Highlights
- New on EvolcAdded 2026-10-29
About Cellmover
Cellmover is a preclinical-stage biotechnology company developing engineered nanobody therapeutics. Its technology targets intracellular immune checkpoints and modulates cellular signaling, with a primary focus on cancer immunotherapy and additional applications in autoimmune diseases.
The company is based in Oslo, Norway. Its team includes scientists, a CEO, and a business development advisor.
Product: Engineered nanobody therapeutics designed to target intracellular proteins and modulate cell signaling.
Jobs at Cellmover
No open positions listed right now.
Leadership
- Marit Inngjerdingen · Founder & ChairmanSource: company website
- Miriam Aarsund Larsen · CEOSource: company website
More biotech & pharma companies
Curida Diatec
Contract manufacturer of nasal spray, ophthalmic liquid and monoclonal antibody products for pharma and biotech clientsNew on EvolcExact Therapeutics
Develops ultrasound-activated drug-delivery technology for pharmaceutical treatments, with a focus on oncologyNew on EvolcGenetic Analysis
Gut microbiome diagnostic tests and laboratory services for diagnostic labs, researchers and pharmaceutical companiesNew on EvolcGentian
Develops and manufactures clinical diagnostic assays and reagents for laboratories and medical diagnostics partnersNew on EvolcHp Halden Pharma
Contract manufacturing of sterile liquid medicines, including IV bags, for pharmaceutical companies worldwideYoung companyNew on EvolcLybe Scientific
Magnetic-bead nucleic acid extraction kits for clinical diagnostic laboratories and life science researchersNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- React
- Sentry
- Wix